Considerations for analysis of clinical samples

Close-up of colorful test tubes with blue caps in a laboratory setting.

When diagnostic tests are implemented in clinical studies there are multiple considerations beyond just the assay and the analyte that are not generally considered but are important. For example: Sample collection, preparation and transport

Standards need to be specified for pre-analysis that would specify the conditions needed even before the analysis are done.

Selection of tubes – The tubes that are used for collection can affect the analyte and need to be carefully considered

Timing of sample transit: How long does it take for the sample to arrive at the testing facility after collection from the patient

Storage: Storage of the samples during transit or even after the transit need to be clear and specified before it can be used.

There are other considerations for samples but this quickly illustrates that the sample journey should be considered in addition to assay parameters: such as limit of detection, thresholds for specificity and sensitivity, causes of interference and other assay specific parameters.

Similar Posts

  • | | |

    Biotech companies

    Small Biotechs: Diagonal Tx: Clustering antibodies that mimic the action of the ligand and bypass the need for the ligand and receptor. This mutation that is created makes standard AI models not useful and so need a new method. This restores new ALK1 signaling in Hereditary Hemorrhagic Telangiectasia. It also treates LoF mutations in ALK1…

  • Acuity measurement

    How does a hospital measure the acuity of an illness? Acuity is defined loosely as the severity of an illness. The more severe an illness or malady is the more attention it deserves. For example, chest pain is critical and deserves attention vs. flu like symptoms do not deserve as much attention. A doctor in…

  • |

    PROTAC databases

    PROTAC (Proteolysis targeting chimera) is fantastic technology that can degrade specific proteins. It uses a small molecule with a capability to bind the protein to be degraded and an active site that binds to E3 ubiquitin ligase. Using the PROTAC pulls the protein into ubiquitin based degradation pathways by ubiquitination of the protein and subsequent…

  • |

    Bile duct cancer

    Bile duct cancer or cholangiocarcinoma, (CCA) is a rare cancer with an incidence of ~3 cases per 100,000 with 10,000 new case diagnosed annually. It is about 10-20% of liver cancers. Interestingly, in Thailand, and some south east asian countries, the incidence is nearly 10 fold higher due to liver fluke infections (Opisthorchis viverrini and…